skip to main content

Clonidine Alpha-2 Agonist — FRCA Primary MCQ

Instant feedback + full explanation. One question, done properly.

EasyPharmacology - AutonomicClonidine Alpha-2 AgonistFRCA Primary

Which adrenergic receptor subtype is the principal pharmacological target of clonidine?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: EAlpha-2 adrenergic receptor

Clonidine is principally a centrally acting alpha-2 adrenergic receptor agonist. Alpha-2 receptors couple to Gi/o proteins, inhibiting adenylyl cyclase and reducing neuronal transmitter release. Central activation reduces sympathetic outflow, causing reductions in heart rate and arterial pressure; relevant anaesthetic effects include sedation, analgesic-sparing activity and reduced volatile anaesthetic requirement. Clonidine also binds imidazoline receptors, so option C describes an additional target but not the principal adrenergic receptor requested. Beta-1 stimulation would increase cardiac rate and contractility, while alpha-1 stimulation predominantly causes vasoconstriction. Muscarinic M2 receptors mediate parasympathetic cardiac effects and are not clonidine's target.

Reference: electronic Medicines Compendium, Clonidine hydrochloride 50 micrograms/5 ml Oral Solution, Summary of Product Characteristics, section 5.1 Pharmacodynamic properties, 2026. https://www.medicines.org.uk/emc/product/101738/smpc